Baloro, Jesrel C.

HRN: 23-89-03  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2024
CEFUROXIME 750MG (VIAL)
05/20/2024
05/27/2024
IVT
230mg
Q8
PCAP-C
Waiting Final Action 
05/20/2024
CEFUROXIME 750MG (VIAL)
05/20/2024
05/27/2024
IVT
230mg
Q8
PCAP-C
Waiting Final Action 
05/20/2024
CEFTRIAXONE 1G (VIAL)
05/20/2024
05/27/2024
IV DRIP
700mg
Q24
Complex Febrile Seizure
Waiting Final Action 
05/21/2024
MUPIROCIN 2%, 15G (TUBE)
05/21/2024
05/28/2024
TOPICAL
1 Mg
BID
Skin Infection
Waiting Final Action 
05/30/2024
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
05/30/2024
06/06/2024
PO VIA OGT
2ml
BID
PCAP-C
Waiting Final Action 
06/05/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/05/2024
06/11/2024
IV
400mg
Q6h
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: